Company intelligence / Profile preview

Cytel

Cambridge, Massachusetts, USAcytel.com ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Cytel is a global leader in statistical software development and contract research services specializing in adaptive clinical trial design, advanced analytics, real-world evidence generation, and biometrics. The company’s platforms are widely used by major biopharma companies to optimize drug development strategies. It does not have its own drug pipeline but enables successful trials for clients through innovative methodologies like group sequential and adaptive designs.

Modalities: small moleculesbiologicsmAbs
Industry: Contract Research Organization

Partnerships

OneMedNetNested Knowledge

Beyond the preview

Go deeper on Cytel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytel.